[go: up one dir, main page]

WO2009034582A3 - Process for the preparation of amorphous fexofenadine hydrochloride - Google Patents

Process for the preparation of amorphous fexofenadine hydrochloride Download PDF

Info

Publication number
WO2009034582A3
WO2009034582A3 PCT/IN2008/000581 IN2008000581W WO2009034582A3 WO 2009034582 A3 WO2009034582 A3 WO 2009034582A3 IN 2008000581 W IN2008000581 W IN 2008000581W WO 2009034582 A3 WO2009034582 A3 WO 2009034582A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
fexofenadine hydrochloride
amorphous
amorphous fexofenadine
fexofenadine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2008/000581
Other languages
French (fr)
Other versions
WO2009034582A2 (en
Inventor
Chidambaram Venkateswaran Srinivasan
Perminder Singh Johar
Lalit Wadhwa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IND-SWIFT LABORATORIES Ltd
Ind Swift Laboratories Ltd
Original Assignee
IND-SWIFT LABORATORIES Ltd
Ind Swift Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IND-SWIFT LABORATORIES Ltd, Ind Swift Laboratories Ltd filed Critical IND-SWIFT LABORATORIES Ltd
Publication of WO2009034582A2 publication Critical patent/WO2009034582A2/en
Anticipated expiration legal-status Critical
Publication of WO2009034582A3 publication Critical patent/WO2009034582A3/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides a process for the preparation of amorphous fexofenadine hydrochloride from fexofenadine via its weak acid addition salt, in high yield and purity. The present invention further provides a process for the preparation of amorphous fexofenadine hydrochloride from fexofenadine acid addition salt.
PCT/IN2008/000581 2007-09-13 2008-09-11 Process for the preparation of amorphous fexofenadine hydrochloride Ceased WO2009034582A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1951/DEL/2007 2007-09-13
IN1951DE2007 2007-09-13

Publications (2)

Publication Number Publication Date
WO2009034582A2 WO2009034582A2 (en) 2009-03-19
WO2009034582A3 true WO2009034582A3 (en) 2010-05-06

Family

ID=40452661

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2008/000581 Ceased WO2009034582A2 (en) 2007-09-13 2008-09-11 Process for the preparation of amorphous fexofenadine hydrochloride

Country Status (1)

Country Link
WO (1) WO2009034582A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090306135A1 (en) * 2008-03-24 2009-12-10 Mukesh Kumar Sharma Stable amorphous fexofenadine hydrochloride
ES2403130B1 (en) * 2010-06-15 2014-09-29 Chemelectiva S.R.L. POLYMORPHIC FORM OF FEXOFENADINE CHLORHYDRATE, INTERMEDIATE COMPOUNDS AND PROCEDURE FOR PREPARATION
WO2012135338A1 (en) * 2011-03-28 2012-10-04 Ratiopharm Gmbh Processes for preparing tofacitinib salts

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005019175A1 (en) * 2003-08-26 2005-03-03 Cipla Limited Fexofenadine polymorphs and processes of preparing the same
WO2006037042A1 (en) * 2004-09-28 2006-04-06 Teva Pharmaceutical Industries Ltd. Fexofenadine crystal form and processes for its preparation thereof
WO2007007347A1 (en) * 2005-07-07 2007-01-18 Wockhardt Limited Industrial process of fexofenadine hydrochloride with controlled side products

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005019175A1 (en) * 2003-08-26 2005-03-03 Cipla Limited Fexofenadine polymorphs and processes of preparing the same
WO2006037042A1 (en) * 2004-09-28 2006-04-06 Teva Pharmaceutical Industries Ltd. Fexofenadine crystal form and processes for its preparation thereof
WO2007007347A1 (en) * 2005-07-07 2007-01-18 Wockhardt Limited Industrial process of fexofenadine hydrochloride with controlled side products

Also Published As

Publication number Publication date
WO2009034582A2 (en) 2009-03-19

Similar Documents

Publication Publication Date Title
WO2008146308A3 (en) Process for the preparation of ivabradine hydrochloride and polymorph thereof
EP2460797A3 (en) Process for preparation of ivabradine hydrochloride
WO2009084024A3 (en) A process for the preparation of r-sit agliptin and its pharmaceutically acceptable salts thereof
ZA200709028B (en) Process for the production of acetic acid
IL198330A0 (en) Process for preparing 2-amino-5-cyanobenzoic acid derivatives
IL211987A0 (en) Novel process for the preparation of amino acid derivatives
WO2010076810A3 (en) A process for the preparation of gefitinib
IL198388A0 (en) Process for preparing 2-amino-5-cyanobenzoic acid derivatives
PL2137206T3 (en) Process for the preparation of tauroursodesoxycholic acid
WO2010070677A3 (en) A process for the preparation of prasugrel and its pharmaceutically acceptable salts thereof
WO2008117305A3 (en) A novel process for preparing pregabalin and its acid addition salts
WO2010083996A8 (en) A process for preparing memantine
WO2010079045A3 (en) Crystalline salt forms of flibanserine
WO2008009970A3 (en) Process for the preparation of montelukast
WO2009037538A3 (en) Process for the preparation of lamivudine form i
WO2011018771A3 (en) Process for the preparation of valganciclovir hydrochloride
WO2011102640A3 (en) Method for preparing sitagliptin and amine salt intermediates used therein
EP2212310A4 (en) An industrially feasible process for the manufacture of bisquinoline derivatives by using substantially pure n-monosubstituted piperazines
WO2009034582A3 (en) Process for the preparation of amorphous fexofenadine hydrochloride
WO2009122429A3 (en) Crystalline oxybutynin and process for preparing the same
EP1927586A4 (en) Process for producing 5-aminolevulinic acid hydrochloride
ZA200701898B (en) Process for preparing hydrocyanic acid
IL218322A0 (en) Process for the preparation of (1s,4r)-2-oxa-3-azabicyclo[2,2,1]hept-5-enes
WO2011048612A3 (en) Process for preparation of propargylated aminoindans or pharmaceutically acceptable salts thereof
WO2008099418A3 (en) An improved process for preparing bupropion hydrochloride

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08808180

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08808180

Country of ref document: EP

Kind code of ref document: A2